{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:38:44Z","timestamp":1768988324411,"version":"3.49.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>E47 has been identified as a modulating transcription factor of glucocorticoid receptor target genes, its loss protecting mice from metabolic adverse effects of glucocorticoids. We aimed to analyze the role of E47 in patients with endogenous glucocorticoid excess [Cushing\u2019s syndrome (CS)] and its association with disorders of lipid and glucose metabolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a prospective cohort study including 120 female patients with CS (ACTH-dependent = 79; ACTH-independent = 41) and 26 healthy female controls. Morning whole blood samples after an overnight fast were used to determine E47 mRNA expression levels in patients with overt CS before and 6\u201312 months after curative surgery. Expression levels were correlated with the clinical phenotype of the patients. Control subjects underwent ACTH stimulation tests and dexamethasone suppression tests to analyze short-term regulation of E47.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>E47 gene expression showed significant differences in patient cohorts with overt CS vs. patients in remission (<jats:italic>p<\/jats:italic> = 0.0474) and in direct intraindividual comparisons pre- vs. post-surgery (<jats:italic>p<\/jats:italic> = 0.0353). ACTH stimulation of controls resulted in a significant decrease of E47 mRNA expression 30\u00a0min after i.v. injection compared to baseline measurements. Administration of 1 mg of dexamethasone overnight in controls did not change E47 mRNA expression. E47 gene expression showed a positive correlation with total serum cholesterol (<jats:italic>p<\/jats:italic> = 0.0036), low-density lipoprotein cholesterol (<jats:italic>p<\/jats:italic> = 0.0157), and waist\u2013arm ratio (<jats:italic>p<\/jats:italic> = 0.0138) in patients with CS in remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>E47 is a GC-dependent gene that is upregulated in GC excess potentially aiming at reducing metabolic glucocorticoid side effects such as\u00a0dyslipidemia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1249863","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:08:45Z","timestamp":1700302125000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["E47 as a novel glucocorticoid-dependent gene mediating lipid metabolism in patients with endogenous glucocorticoid excess"],"prefix":"10.3389","volume":"14","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Nowotny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marily","family":"Theodoropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte M.","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bidlingmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias K.","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette","family":"Uhlenhaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0984-8","article-title":"Cushing's disease: the burden of illness","volume":"56","author":"Pivonello","year":"2017","journal-title":"Endocrine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.04.012","article-title":"Cushing's syndrome","volume":"24","author":"Shibli-Rahhal","year":"2006","journal-title":"Clin Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1095","article-title":"The burden of Cushing's disease: clinical and health-related quality of life aspects","volume":"167","author":"Feelders","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.43.645","article-title":"Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM","volume":"43","author":"Friedman","year":"1996","journal-title":"Endocr J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490543","article-title":"Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2015.04.007","article-title":"Specificity and sensitivity of glucocorticoid signaling in health and disease","volume":"29","author":"Cain","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mce.2013.03.002","article-title":"Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor","volume":"380","author":"Miranda","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ng.759","article-title":"Chromatin accessibility pre-determines glucocorticoid receptor binding patterns","volume":"43","author":"John","year":"2011","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-2895-8_1","article-title":"Regulatory actions of glucocorticoid hormones: from organisms to mechanisms","volume":"872","author":"Granner","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1101\/gr.188581.114","article-title":"Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid","volume":"25","author":"Lim","year":"2015","journal-title":"vivo. Genome Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80421-5","article-title":"Both E12 and E47 allow commitment to the B cell lineage","volume":"6","author":"Bain","year":"1997","journal-title":"Immunity"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06452-11","article-title":"Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47","volume":"32","author":"Teachenor","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603728103","article-title":"Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development","volume":"103","author":"Schwartz","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41467-018-08196-5","article-title":"E47 modulates hepatic glucocorticoid action","volume":"10","author":"Hemmer","year":"2019","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0689","article-title":"Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's Registry","volume":"176","author":"Berr","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/ejendo\/lvac016","article-title":"Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation","author":"Braun","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02719-9","article-title":"Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study","volume":"73","author":"Braun","year":"2021","journal-title":"Endocrine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.celrep.2019.04.041","article-title":"Glucocorticoid-induced obesity develops independently of UCP1","volume":"27","author":"Luijten","year":"2019","journal-title":"Cell Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2014.03.004","article-title":"Wnt\/beta-catenin signaling pathway and lipolysis enzymes participate in methylprednisolone induced fat differential distribution between subcutaneous and visceral adipose tissue","volume":"84","author":"Xiao","year":"2014","journal-title":"Steroids"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.11189","article-title":"The diagnosis and differential diagnosis of endogenous Cushing's syndrome","volume":"5","author":"Makras","year":"2006","journal-title":"Hormones (Athens)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1249863\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:08:49Z","timestamp":1700302129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1249863\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":26,"alternative-id":["10.3389\/fendo.2023.1249863"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1249863","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"article-number":"1249863"}}